Makerere University

About: Makerere University is a education organization based out in Kampala, Uganda. It is known for research contribution in the topics: Population & Public health. The organization has 7220 authors who have published 12405 publications receiving 366520 citations. The organization is also known as: Makerere University Kampala & MUK.

Remedy or Cure for Service Failure? : Effects of Service Recovery on Customer Satisfaction and Loyalty

Abstract: Purpose: This paper aims to contribute to a growing body of service recovery knowledge by examining the relationship between service recovery, consumer satisfaction and loyalty in a commercial bank ...

The Forest Birds of Kenya and Uganda

Abstract: Robust and rapid ways of assessing and monitoring forest biodiversity are increasingly necessary. To this end, we present a classification of forest birds in Kenya and Uganda into three simple categories: forest-specialists (FF species), forest generalists (F species) and forest visitors (f species). FF and F species, but not f species, are dependent on forests. Out of 479 forest birds in the two countries, 214 are FF, 156 F and 109 f species. Forest-dependent birds, and particularly forest specialists, are less widespread than forest visitors. Uganda has 420 forest birds compared to Kenya's 335, and a higher proportion of forest specialists: this reflects differences in forest structure and biogeography, rather than the area of natural forest. Using this classification allows species lists and densities to be interpreted more meaningfully. The number of FF species is an initial measure of a forest's relative conservation importance, while the proportion of FF, F and f species and their relative ...

Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Malaria: A Randomized Trial

Abstract: Objectives: To compare the efficacy and safety of artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) for treating uncomplicated falciparum malaria in Uganda. Results: Of 421 enrolled participants, 417 (99%) completed follow-up. The unadjusted risk of recurrent falciparum parasitemia was significantly lower for participants treated with DP than for those treated with AL after 28 d (11% versus 29%; risk difference (RD) 18%, 95% confidence interval (CI) 11%-26%) and 42 d (43% versus 53%; RD 9.6%, 95% CI 0%-19%) of follow-up. Similarly, the risk of recurrent parasitemia due to possible recrudescence (adjusted by genotyping) was significantly lower for participants treated with DP than for those treated with AL after 28 d (1.9% versus 8.9%; RD 7.0%, 95% CI 2.5%-12%) and 42 d (6.9% versus 16%; RD 9.5%, 95% CI 2.8%-16%). Patients treated with DP had a lower risk of recurrent parasitemia due to non-falciparum species, development of gametocytemia, and higher mean increase in hemoglobin compared to patients treated with AL. Both drugs were well tolerated; serious adverse events were uncommon and unrelated to study drugs.

Male partner antenatal attendance and HIV testing in eastern Uganda: a randomized facility-based intervention trial

Abstract: The objective of the study was to evaluate the effect of a written invitation letter to the spouses of new antenatal clinic attendees on attendance by couples and on male partner acceptance of HIV testing at subsequent antenatal clinic visits.